Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001390478-14-000058
Filing Date
2014-10-31
Accepted
2014-10-31 16:50:10
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3/A gale-20141031formsx3xzuple.htm S-3/A 482877
2 EXHIBIT exhibit231-consentofmossad.htm EX-23.1 2592
3 EXHIBIT exhibit232-consentofbdousa.htm EX-23.2 2995
4 GRAPHIC aprils3image1a01.jpg GRAPHIC 26426
5 GRAPHIC pipeline4a02.jpg GRAPHIC 72944
  Complete submission text file 0001390478-14-000058.txt   626967
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-199517 | Film No.: 141187091
SIC: 2834 Pharmaceutical Preparations